Dementia due to use of volatile inhalants
Dementia due to use of volatile inhalants is characterized by the development of persistent cognitive impairments (e.g., memory problems, language impairment, and an inability to perform complex motor tasks) that meet the definitional requirements of Dementia that are judged to be a direct consequence of inhalant use or exposure and that persist beyond the usual duration of action or withdrawal syndrome associated with the substance. The amount and duration of inhalant use or exposure must be sufficient to be capable of producing the cognitive impairment. The cognitive impairment is not better accounted for by a disorder that is not induced by volatile inhalants such as a dementia due to another medical condition.
Differential diagnosis
When diagnosing Dementia due to use of volatile inhalants, the following ICD-11 disorders should be considered in the differential diagnosis:
Frequently asked questions
What disorders are in the differential diagnosis of Dementia due to use of volatile inhalants?
The differential diagnosis of Dementia due to use of volatile inhalants (6D84.2) includes: Otępienie spowodowane narażeniem na metale ciężkie i inne toksyny (6D85.2).
WHO ICD-11 source
View this entry in the official WHO ICD-11 browser: 6D84.2 – WHO ICD-11
Open in interactive browser →